EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer

Hypersecretory malignant cells underlie therapeutic resistance, metastasis, and poor clinical outcomes. However, the molecular basis for malignant hypersecretion remains obscure. Here, we showed that epithelial-mesenchymal transition (EMT) initiates exocytic and endocytic vesicular trafficking programs in lung cancer. The EMT-activating transcription factor zinc finger E-box–binding homeobox 1 (ZEB1) executed a PI4KIIIβ-to-PI4KIIα (PI4K2A) dependency switch that drove PI4P synthesis in the Golgi and endosomes. EMT enhanced the vulnerability of lung cancer cells to PI4K2A small-molecule antagonists. PI4K2A formed a MYOIIA-containing protein complex that facilitated secretory vesicle biogenesis in the Golgi, thereby establishing a hypersecretory state involving osteopontin (SPP1) and other prometastatic ligands. In the endosomal compartment, PI4K2A accelerated recycling of SPP1 receptors to complete an SPP1-dependent autocrine loop and interacted with HSP90 to prevent lysosomal degradation of AXL receptor tyrosine kinase, a driver of cell migration. These results show that EMT coordinates exocytic and endocytic vesicular trafficking to establish a therapeutically actionable hypersecretory state that drives lung cancer progression.

[1]  B. Zhu,et al.  High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity , 2022, Cancer medicine.

[2]  M. Bentires-Alj,et al.  Feed‐forward loops between metastatic cancer cells and their microenvironment—the stage of escalation , 2022, EMBO molecular medicine.

[3]  Jing Wang,et al.  The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8+ cytotoxic T-cell response , 2022, Genes & development.

[4]  D. Gibbons,et al.  Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis , 2022, Cells.

[5]  D. Lauffenburger,et al.  Towards targeting of shared mechanisms of cancer metastasis and therapy resistance , 2022, Nature Reviews Cancer.

[6]  Jing Wang,et al.  The EMT activator ZEB1 accelerates endosomal trafficking to establish a polarity axis in lung adenocarcinoma cells , 2021, Nature Communications.

[7]  M. Saber-Ayad,et al.  Highlights on the Role of KRAS Mutations in Reshaping the Microenvironment of Pancreatic Adenocarcinoma , 2021, International journal of molecular sciences.

[8]  J. Hancock,et al.  Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity , 2021, Nature Communications.

[9]  Jing Wang,et al.  Addiction to Golgi-resident PI4P synthesis in chromosome 1q21.3–amplified lung adenocarcinoma cells , 2021, Proceedings of the National Academy of Sciences.

[10]  C. Creighton,et al.  p53 loss activates prometastatic secretory vesicle biogenesis in the Golgi , 2021, Science Advances.

[11]  Jing Wang,et al.  Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity , 2021, Cell reports.

[12]  B. Győrffy,et al.  Pancancer survival analysis of cancer hallmark genes , 2020, Scientific Reports.

[13]  C. Creighton,et al.  A pro-tumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma. , 2020, The Journal of clinical investigation.

[14]  N. Alon,et al.  Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome , 2020, Nature Communications.

[15]  S. Schmid,et al.  FCHSD2 controls oncogenic ERK1/2 signaling outcome by regulating endocytic trafficking , 2020, bioRxiv.

[16]  P. Brown,et al.  PI4KIIIβ is a therapeutic target in chromosome 1q–amplified lung adenocarcinoma , 2020, Science Translational Medicine.

[17]  Jing Wang,et al.  Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells , 2019, Oncogene.

[18]  Michelle M. Ng,et al.  Efficient Golgi Forward Trafficking Requires GOLPH3-Driven, PI4P-Dependent Membrane Curvature. , 2019, Developmental cell.

[19]  M. Waugh.  The Great Escape: how phosphatidylinositol 4-kinases and PI4P promote vesicle exit from the Golgi (and drive cancer). , 2019, The Biochemical journal.

[20]  D. Xie,et al.  CHML promotes liver cancer metastasis by facilitating Rab14 recycle , 2019, Nature Communications.

[21]  R. Torka,et al.  Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation , 2019, Cell Communication and Signaling.

[22]  Y. Funakami,et al.  Emerging Evidence of Translational Control by AU-Rich Element-Binding Proteins , 2019, Front. Genet..

[23]  W. Lu,et al.  Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis. , 2019, Developmental cell.

[24]  H. Ovaa,et al.  USP32 regulates late endosomal transport and recycling through deubiquitylation of Rab7 , 2019, Nature Communications.

[25]  T. Balla,et al.  Phosphatidylinositol 4,5‐bisphosphate controls Rab7 and PLEKHM1 membrane cycling during autophagosome–lysosome fusion , 2019, The EMBO journal.

[26]  B. Stanger,et al.  The tumor as organizer model , 2019, Science.

[27]  B. Zeng,et al.  SPP1 promotes ovarian cancer progression via Integrin β1/FAK/AKT signaling pathway , 2018, OncoTargets and therapy.

[28]  Jiangmei Li,et al.  PI4KIIα regulates insulin secretion and glucose homeostasis via a PKD-dependent pathway , 2018, Biophysics reports.

[29]  Hualiang Jiang,et al.  PI-273, a Substrate-Competitive, Specific Small-Molecule Inhibitor of PI4KIIα, Inhibits the Growth of Breast Cancer Cells. , 2017, Cancer research.

[30]  C. Pilarsky,et al.  The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer , 2017, Nature Cell Biology.

[31]  C. Creighton,et al.  Epithelial-to-mesenchymal transition drives a pro-metastatic Golgi compaction process through scaffolding protein PAQR11 , 2017, The Journal of clinical investigation.

[32]  J. Kriston-Vizi,et al.  Phosphatidylinositol 4-kinase IIβ negatively regulates invadopodia formation and suppresses an invasive cellular phenotype , 2016, Molecular biology of the cell.

[33]  L. Rezabkova,et al.  Structural insights and in vitro reconstitution of membrane targeting and activation of human PI4KB by the ACBD3 protein , 2016, Scientific Reports.

[34]  S. Minogue,et al.  PtdIns4KIIα generates endosomal PtdIns(4)P and is required for receptor sorting at early endosomes , 2016, Molecular biology of the cell.

[35]  S. Tavazoie,et al.  PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion. , 2016, Cancer cell.

[36]  A. Gautreau,et al.  Persistent cell migration and adhesion rely on retrograde transport of β1 integrin , 2015, Nature Cell Biology.

[37]  E. Bouřa,et al.  Phosphatidylinositol 4-kinases: Function, structure, and inhibition. , 2015, Experimental cell research.

[38]  J. von Blume,et al.  Secretory cargo sorting at the trans-Golgi network. , 2014, Trends in cell biology.

[39]  Lixia Diao,et al.  Metastasis is regulated via microRNA-200/ZEB1 axis control of tumor cell PD-L1 expression and intratumoral immunosuppression , 2014, Nature Communications.

[40]  A. Gingras,et al.  Endosomal sorting of VAMP3 is regulated by PI4K2A , 2014, Journal of Cell Science.

[41]  I. Wistuba,et al.  ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. , 2014, The Journal of clinical investigation.

[42]  Hua Kang,et al.  Dual inhibition of EGFR at protein and activity level via combinatorial blocking of PI4KIIα as anti-tumor strategy , 2014, Protein & Cell.

[43]  Pengyuan Yang,et al.  Microenvironmental regulation of cancer metastasis by miRNAs. , 2014, Trends in cell biology.

[44]  J. Zucman‐Rossi,et al.  Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma , 2014, BMC Cancer.

[45]  P. Meltzer,et al.  A p21-ZEB1 Complex Inhibits Epithelial-Mesenchymal Transition through the MicroRNA 183-96-182 Cluster , 2013, Molecular and Cellular Biology.

[46]  M. Santoro,et al.  Molecular Mechanism of 17-Allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL Receptor Tyrosine Kinase Degradation* , 2013, The Journal of Biological Chemistry.

[47]  Michael Peyton,et al.  An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance , 2012, Clinical Cancer Research.

[48]  G. Goodall,et al.  ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression. , 2012, The Journal of clinical investigation.

[49]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[50]  A. Menssen,et al.  miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions , 2011, Cell cycle.

[51]  Chen-Chung Lin,et al.  A KLF4–miRNA-206 Autoregulatory Feedback Loop Can Promote or Inhibit Protein Translation Depending upon Cell Context , 2011, Molecular and Cellular Biology.

[52]  C. Burd,et al.  Coordination of Golgi functions by phosphatidylinositol 4-kinases. , 2011, Trends in cell biology.

[53]  Elizabeth Garrett-Mayer,et al.  ZEB1-responsive genes in non-small cell lung cancer. , 2011, Cancer letters.

[54]  G. Chalancon,et al.  Rab and actomyosin-dependent fission of transport vesicles at the Golgi complex , 2010, Nature Cell Biology.

[55]  P. Guyre,et al.  Estradiol Suppresses NF-κB Activation through Coordinated Regulation of let-7a and miR-125b in Primary Human Macrophages , 2010, The Journal of Immunology.

[56]  Julia Schüler,et al.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.

[57]  Michelle M. Ng,et al.  GOLPH3 Bridges Phosphatidylinositol-4- Phosphate and Actomyosin to Stretch and Shape the Golgi to Promote Budding , 2009, Cell.

[58]  Alexander Pertsemlidis,et al.  Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. , 2009, Genes & development.

[59]  Olivier Voinnet,et al.  Revisiting the principles of microRNA target recognition and mode of action , 2009, Nature Reviews Molecular Cell Biology.

[60]  U. A. Ørom,et al.  MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. , 2008, Molecular cell.

[61]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[62]  V. Faundez,et al.  Phosphatidylinositol-4-kinase type II alpha contains an AP-3-sorting motif and a kinase domain that are both required for endosome traffic. , 2008, Molecular biology of the cell.

[63]  J. Hsuan,et al.  Phosphatidylinositol 4-kinase type II-alpha , 2008 .

[64]  T. Nicolson,et al.  Integration of Golgi trafficking and growth factor signaling by the lipid phosphatase SAC1 , 2008, The Journal of cell biology.

[65]  P. Várnai,et al.  A plasma membrane pool of phosphatidylinositol 4-phosphate is generated by phosphatidylinositol 4-kinase type-III alpha: studies with the PH domains of the oxysterol binding protein and FAPP1. , 2005, Molecular biology of the cell.

[66]  P. De Camilli,et al.  Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Robert H. Singer,et al.  Single mRNA Molecules Demonstrate Probabilistic Movement in Living Mammalian Cells , 2003, Current Biology.

[68]  M. Glimcher,et al.  Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1) , 1996, Science.